The biopharmaceutical industry has been witnessing drastic changes in recent years, prompting the need for a robust Competitive Intelligence function that can help organizations anticipate and deploy strategic responses to external threats and opportunities. The business model, structure, resources and activities of the Competitive Intelligence function have a significant impact on its effectiveness.
Best Practices, LLC conducted this landscape assessment using a meta-analysis approach to identify evolutionary insights and trends for Competitive Intelligence structure, staffing and investment. Insights in this research have been distilled from ten of Best Practices, LLC’s existing benchmarking studies.
This report delivers specific benchmarks around Competitive Intelligence business models, structure, policies, activities, investment, staffing, reporting levels, service levels, technology enablement, communication channels and frequencies, insight types, hallmarks of excellence, and use of centers of excellence.